News

A credit card sized leaflet summarising the facts about bowel cancer. This explains what symptoms to look out for and how to reduce your risk. This pocket sized leaflet is ideal for awareness-raising ...
Bacteria commonly found in our guts could contribute to the development of bowel cancer, according to a new study published in Nature today.
The results of the Cancer Prevention Project 3 (CaPP3) trial, a study changing how we think about aspirin and cancer prevention for people with Lynch syndrome.
With the support of BBC Radio 1 DJ Adele Roberts we're launching our new campaign to help people know the red flag symptoms of bowel cancer. Read more.
The number of people in England waiting longer than six weeks for tests that can help to diagnose bowel cancer has increased by nearly eight-fold compared to pre-pandemic levels, according to figures ...
Aspirin taken daily for more than two years could reduce the risk of bowel cancer in people with Lynch syndrome, NICE (The National Institute for Health and Care Excellence) has said in new draft ...
A new report out today shows bowel cancer costs the UK economy more than £1.7 billion (€1.9 billion) a year. The report, commissioned by Digestive Cancers Europe, calculated the cost of diagnosis and ...
We're delighted to announce our groundbreaking campaign has been named Corporate National Partnership of the Year with a Retailer at the Charity Times Awards 2023.
In 2013, NHS England began rolling out a screening test for bowel cancer for people aged 55, known as bowel scope screening. Bowel scope has been used in England alongside the home screening test, FIT ...
A new study has found that increasing the sensitivity of the faecal immunochemical test (FIT) can help to identify more cases of bowel cancer, advanced polyps (non-cancerous growths) and Inflammatory ...
Updated surveillance guidance for people who have had polyps or previous cancer removed Thursday 28 November 2019 ...
Our new five-year strategy sets out how we'll continue to work relentlessly towards our vision of a future where nobody dies from bowel cancer. Our Chief Executive Officer Genevieve Edwards tells us ...